Vaxart(VXRT) - 2025 Q4 - Earnings Call Transcript

Vaxart (NasdaqCM:VXRT) Q4 2025 Earnings call March 12, 2026 04:30 PM ET Company ParticipantsCheng Li - Director of Biotech Equity ResearchEdward Berg - SVP and General CounselJames Cummings - CMOJeroen Grasman - CFOMayank Mamtani - Senior Managing Director and Group Head of Healthcare ResearchSean Tucker - Founder and Chief Scientific OfficerSteven Lo - President and CEOOperatorGreetings, and welcome to the Vaxart fourth quarter business update and year-end 2025 financial results conference call. A question ...